U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT07479615) titled 'A Study to Evaluate the Efficacy and Safety of MG-K10 in Participants Who Have Atopic Dermatitis' on March 11.
Brief Summary: Rationale (What is the reason for this study?) Atopic dermatitis (AD) is a condition that makes the skin dry and itchy and is the most common skin condition that causes redness and irritation.
The exact cause of AD is unclear but genetic and environmental factors are believed to play a role. Common treatment options for participants with AD include basic skin care, medicine that is applied to the skin, and medicine that works in more than one part of the body. Typically, these treatment options work for par...